Summary
Cipla has announced a partnership with China's Qilu Pharma to develop and commercialize a cancer biosimilar, reinforcing Cipla's focus on its oncology portfolio and confidence in the biosimilars market.
Summary
Cipla has announced a partnership with China's Qilu Pharma to develop and commercialize a cancer biosimilar, reinforcing Cipla's focus on its oncology portfolio and confidence in the biosimilars market.
Turn this story into an image post, carousel, video, audio reel, blog, and more — all from HyperFast News.
Pick a story, apply your brand template, and publish polished graphics to Facebook, Instagram, LinkedIn, and more — without opening a design tool.
Create Image PostDescribe the story, headline, colors, and style you want.
Try Prompt to PostCombine branded news graphics with narration — from your audio library, a live recording, or AI text-to-speech — and share as engaging short-form content.
Create Audio PostUpload your footage, apply a video template with baked-in headlines, add optional audio, and schedule posts across every connected social channel.
Create Video PostCombine several news items into a single swipeable carousel post — with a shared title, unified caption, and per-slide template content for maximum engagement.
Create CarouselUpload your media, craft the perfect caption with AI assistance, preview on every platform, and schedule posts for the exact moment your audience is online.
Schedule a PostTransform breaking news into long-form, SEO-optimized blog posts with AI writing, a rich text editor, featured images, and one-click social image post creation.
Create Blog PostTurn any news article into a professional anchor video with AI-generated presenters, natural voice narration, and lip-sync animation — no studio, no crew, no wait.
Learn moreAbout the public HyperFast News news feed powered by NewsEngine.
Purpose-built AI tools and business automation workflows for publishers, stores, agencies, and brands.
Products
© 2026 HyperFast. All Rights Reserved.
An initiative of Xzect Labs Private Limited
Cipla Partners with China's Qilu for US Launch of Merck's Keytruda Biosimilar
18 Sept 2026, 4:52 pm · News
Pharma Giant Cipla Completes Merger with Wholly-Owned Subsidiary Inzpera Health Sciences
18 Sept 2026, 4:52 pm · News
Cipla, Rocket India Announce ₹300 Crore Karnataka Expansion; Blackstone Eyes Data Centers
18 Sept 2026, 4:52 pm · News
Cipla Q1 Net Dips 39% to ₹785.55 Crore as North America Business Drags
18 Sept 2026, 4:52 pm · News
Cipla Q1 Results: Cons Profit Drops 39% YoY to Rs 789 Crore; Revenue Rises Marginally
18 Sept 2026, 4:52 pm · News